SCHEMBL30564458

SCHEMBL30564458

CC(C(=O)O)c1ccc2ncccc2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 9/20 0.70
AKR1C2 P52895 9/20 0.70
AKR1B1 P15121 1/20 0.51
ALDH1A1 P00352 2/20 0.51
LMNA P02545 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ALOX15 P16050 1/20 0.50
HTT P42858 1/20 0.50
PLK1 P53350 1/20 0.50
PTGS1 P23219 3/20 0.49
ABCC4 O15439 1/20 0.49
PTGS2 P35354 3/20 0.49
NPC1 O15118 2/20 0.49
POLB P06746 2/20 0.49
CDC42 P60953 1/20 0.49
RAC1 P63000 1/20 0.49
CYP1A2 P05177 1/20 0.49
TSHR P16473 1/20 0.49
SLC22A6 Q4U2R8 1/20 0.49
MEN1 O00255 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492942 1.00 AKR1C3 (0.70) AKR1C3AKR1C2AKR1B1ALDH1A1LMNA
SCHEMBL2341919 1.00 AKR1C3 (0.70) AKR1C3AKR1C2AKR1B1ALDH1A1LMNA
SCHEMBL28169181 0.89 AKR1C3 (0.57) AKR1C3AKR1C2ALDH1A1LMNASMN1; SMN2
SCHEMBL30564459 0.88 AKR1C3 (0.60) AKR1C3AKR1C2AKR1B1ALDH1A1PTGS1
SCHEMBL9910479 0.86 AKR1C3 (0.55) AKR1C3AKR1C2ALDH1A1LMNASMN1; SMN2
SCHEMBL30314473 0.86 AKR1C3 (0.55) AKR1C3AKR1C2ALDH1A1LMNASMN1; SMN2
Hydrochloric Acid SCHEMBL2696415 0.85 AKR1C3 (0.54) AKR1C3AKR1C2ALDH1A1LMNASMN1; SMN2
SCHEMBL1669333 0.84 ALOX15 (0.57) AKR1C3AKR1C2ALDH1A1LMNASMN1; SMN2
SCHEMBL27755472 0.82 AKR1C3 (0.55) AKR1C3AKR1C2ALDH1A1LMNASMN1; SMN2
SCHEMBL3594072 0.82 AKR1C3 (0.52) AKR1C3AKR1C2ALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118406007-A Synthesis method of 3- (quinoline-6-yl) propionic acid 上海毕得医药科技股份有限公司 2024-07-30 CN claimed
CN-118406007-A Synthesis method of 3- (quinoline-6-yl) propionic acid 上海毕得医药科技股份有限公司 2024-07-30 CN disclosed
CN-118406007-A Synthesis method of 3- (quinoline-6-yl) propionic acid 上海毕得医药科技股份有限公司 2024-07-30 CN disclosed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP AKR1C3 4578/4885AKR1C2 4274/4885AKR1B1 4239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.